Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies

by Annelisa M. Cornel, Niek P. van Til, Jaap Jan Boelens, Jaap Jan Boelens, Jaap Jan Boelens, Stefan Nierkens
Published 2018-05-01

Morbidity and Mortality Associated With Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplant: Too Little Defense or Harmful Immunity?

by Anne Birgitta Versluys, Jaap Jan Boelens
Published 2018-11-01

Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization

by Jaap Jan Boelens, Kinga K. Hosszu, Stefan Nierkens
Published 2020-08-01

Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism

by Emily Y. Tan, Jaap Jan Boelens, Simon A. Jones, Robert F. Wynn
Published 2019-10-01

Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective

by Shanice Beerepoot, Stefan Nierkens, Jaap Jan Boelens, Caroline Lindemans, Marianna Bugiani, Nicole I. Wolf
Published 2019-11-01

Allogeneic Haematopoietic Cell Transplantation for Epidermolysis Bullosa: the Dutch Experience

by Katarzyna B. Gostyńska, Vamsi K. Yenamandra, Caroline Lindemans, José Duipmans, Antoni Gostyński, Marcel F. Jonkman, Jaap-Jan Boelens
Published 2018-12-01

Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications

by Vania Lo Presti, Annelisa M. Cornel, Maud Plantinga, Ester Dünnebach, Jurgen Kuball, Jaap Jan Boelens, Stefan Nierkens, Niek P. van Til
Published 2021-06-01

Clinical Grade Production of Wilms’ Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation

by Maud Plantinga, Vania Lo Presti, Colin G. de Haar, Ester Dünnebach, Alejandro Madrigal, Caroline A. Lindemans, Jaap Jan Boelens, Stefan Nierkens, Stefan Nierkens
Published 2020-09-01

Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors

by Maud Plantinga, Colin G. de Haar, Ester Dünnebach, Denise A. M. H. van den Beemt, Kitty W. M. Bloemenkamp, Michal Mokry, Jaap Jan Boelens, Stefan Nierkens
Published 2019-02-01

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation

by Jurgen B. Langenhorst, Thomas P.C. Dorlo, Charlotte vanKesteren, Erik M. vanMaarseveen, Stefan Nierkens, Moniek A. deWitte, Jaap Jan Boelens, Alwin D.R. Huitema
Published 2020-05-01

Therapy-type related long-term outcomes in mucopolysaccaridosis type II (Hunter syndrome) – Case series

by Mojca Zerjav Tansek, Jana Kodric, Simona Klemencic, Jaap Jan Boelens, Peter M. van Hasselt, Ana Drole Torkar, Maja Doric, Alenka Koren, Simona Avcin, Tadej Battelino, Urh Groselj
Published 2021-09-01

New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS)

by Brigitte W. M. Willemse, Saskia N. van der Crabben, Wilhelmina S. Kerstjens-Frederikse, Wim Timens, Joris M. van Montfrans, Caroline A. Lindemans, Jaap Jan Boelens, Marije P. Hennus, Gijs van Haaften
Published 2021-03-01

Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma

by Celina L. Szanto, Annelisa M. Cornel, Sara M. Tamminga, Eveline M. Delemarre, Coco C. H. de Koning, Denise A. M. H. van den Beemt, Ester Dunnebach, Michelle L. Tas, Miranda P. Dierselhuis, Lieve G. A. M. Tytgat, Max M. van Noesel, Kathelijne C. J. M. Kraal, Jaap-Jan Boelens, Alwin D. R. Huitema, Stefan Nierkens
Published 2021-04-01